| Issuer Name: | Lyra Therapeutics Inc. | State/Country: | MASSACHUSETTS | IPO: | 2020 | CIK: | 1327273 |
| Industry: | medical specialty equipment/services | Sector: | health care | Fiscal Year End: | Dec 31 | investors.lyratherapeutics.com | |
|
Period:2024-12-31
C: 2 / 4
S: 18110 / 272748 |
Period:2024-09-30
C: 32 / 24
S: 5.84 M / 3.53 M |
| Holding Shares: | 36.97 Mil (Pct:56.0% 3M:-21.99% 1Yr:2.0%) | Institutions reported:? | 5/63 (Acq:40% Dis:20% Res:40% Sold out:80%) | SC 13g/13d:? | 3M:5(mktqtl:0.99) 6M:5(mktqtl:0.98) |
| Industry Quantile: | 40.0% (3M:-14.99% 1Yr:-7.99%) | Sector Quantile: | 42.0% (3M:-20.99% 1Yr:-7.99%) | Market Quantile: | 39.0% (3M:-22.99% 1Yr:-5.99%) |
| FIGI ID: | BBG001J2N202 |
(13F reporting period:2024-12-31 Data last updated 2025-02-01 06:57:30 -0600 US CDT
|
|
|
|
Notes: Data summarized from Form 13F/13G/13D reports filed to the SEC.
Data is updated daily between 5am and 7am CDT (except holidays).
Corrections were automatically applied to holding values where per share price obviously deviates from market median.
Details of Holding Changes & Schedule 13G/D Filings
COMMON STOCK CSV download
| Filing Date | Institution | Operationa | Reporting Period(last) | Shares(last) | Reporting Period | Shares | Value$1000 USD | Holding Change%b | Portfolio%c |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-30 | RHUMBLINE ADVISERS | Restatement | 2024-09-30 | 41258 | 2024-12-31 | 41258 | 8495 | 0.0% | 0.0% |
| 2025-01-28 | WILMINGTON SAVINGS FUND SOCIETY, FSB | Restatement | 2024-09-30 | 1025 | 2024-12-31 | 1025 | 212 | 0.0% | 0.0% |
| 2025-01-23 | ABEL HALL, LLC | Acquire | 2024-12-31 | 17647 | 3642 | 100.0% | 0.2% | ||
| 2025-01-17 | SG AMERICAS SECURITIES, LLC | Dispose | 2024-09-30 | 36409 | 2024-12-31 | 31907 | 7000 | -12.36% | 0.0% |
| 2024-12-05 | CATALYST FUNDS MANAGEMENT PTY LTD | Acquire | 2024-03-31 | 8200 | 51004 | 100.0% | 0.44% | ||
| 2024-11-25 | WILMINGTON SAVINGS FUND SOCIETY, FSB | Acquire | 2024-09-30 | 1025 | 263 | 100.0% | 0.0% | ||
| 2024-11-15 | JANE STREET GROUP, LLC | Acquire | 2024-06-30 | 42676 | 2024-09-30 | 54601 | 14033 | 27.94% | 0.0% |
| 2024-11-15 | BARCLAYS PLC | Acquire | 2024-06-30 | 16604 | 2024-09-30 | 63303 | 16000 | 281.25% | 0.0% |
| 2024-11-15 | NATIONAL BANK OF CANADA /FI/ | Restatement | 2024-09-30 | 3700 | 2024-09-30 | 3700 | 951 | 0.0% | 0.0% |
| 2024-11-14 | GOLDMAN SACHS GROUP INC | Acquire | 2024-06-30 | 24391 | 2024-09-30 | 547339 | 140666 | 2144.02% | 0.01% |
| 2024-11-14 | UBS GROUP AG | Acquire | 2024-06-30 | 14697 | 2024-09-30 | 24915 | 6404 | 69.52% | 0.0% |
| 2024-11-14 | PERCEPTIVE ADVISORS LLC | Restatement | 2024-06-30 | 12757562 | 2024-09-30 | 12757562 | 3278693 | 0.0% | 0.94% |
| 2024-11-14 | CITADEL ADVISORS LLC | Dispose | 2024-06-30 | 4796816 | 2024-09-30 | 4794316 | 1232140 | -0.04% | 0.06% |
| 2024-11-14 | DIVERSIFIED ENTERPRISES, LLC | Acquire | 2024-09-30 | 11932 | 3067 | 100.0% | 0.34% | ||
| 2024-11-14 | TOWER RESEARCH CAPITAL LLC | Acquire | 2024-06-30 | 6822 | 2024-09-30 | 15123 | 3887 | 121.68% | 0.01% |
| 2024-11-14 | SAMSARA BIOCAPITAL, LLC | Restatement | 2024-06-30 | 2780261 | 2024-09-30 | 2780261 | 714527 | 0.0% | 0.79% |
| 2024-11-14 | IKARIAN CAPITAL, LLC | Restatement | 2024-06-30 | 1056829 | 2024-09-30 | 1056829 | 271606 | 0.0% | 0.38% |
| 2024-11-14 | ALLIANCEBERNSTEIN L.P. | Restatement | 2024-06-30 | 33120 | 2024-09-30 | 33120 | 8512 | 0.0% | 0.0% |
| 2024-11-14 | TWO SIGMA ADVISERS, LP | Dispose | 2024-06-30 | 681600 | 2024-09-30 | 460300 | 118297 | -32.46% | 0.01% |
| 2024-11-14 | BEACON POINTE ADVISORS, LLC | Acquire | 2024-09-30 | 77112 | 19818 | 100.0% | 0.09% | ||
| 2024-11-14 | BOOTHBAY FUND MANAGEMENT, LLC | Restatement | 2024-06-30 | 232670 | 2024-09-30 | 232670 | 59796 | 0.0% | 0.01% |
| 2024-11-14 | GENEOS WEALTH MANAGEMENT INC. | Acquire | 2024-09-30 | 3538 | 920 | 100.0% | 0.01% | ||
| 2024-11-14 | XTX TOPCO LTD | Dispose | 2024-06-30 | 33951 | 2024-09-30 | 17776 | 4568 | -47.63% | 0.0% |
| 2024-11-14 | MORGAN STANLEY | Dispose | 2024-06-30 | 811745 | 2024-09-30 | 652381 | 167663 | -19.62% | 0.01% |
| 2024-11-14 | ROYAL BANK OF CANADA | Acquire | 2024-06-30 | 4873 | 2024-09-30 | 6171 | 1000 | 26.64% | % |
| 2024-11-14 | BANK OF AMERICA CORP /DE/ | Dispose | 2024-06-30 | 86459 | 2024-09-30 | 49228 | 12651 | -43.05% | 0.0% |
| 2024-11-14 | TWO SIGMA INVESTMENTS, LP | Dispose | 2024-06-30 | 490861 | 2024-09-30 | 282547 | 72615 | -42.43% | 0.0% |
| 2024-11-14 | AQR CAPITAL MANAGEMENT LLC | Acquire | 2024-09-30 | 54030 | 13885 | 100.0% | 0.0% | ||
| 2024-11-14 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | Acquire | 2024-09-30 | 26554 | 6824 | 100.0% | 0.0% | ||
| 2024-11-14 | STATE STREET CORP | Acquire | 2024-06-30 | 259820 | 2024-09-30 | 488720 | 125601 | 88.1% | 0.01% |
aHolding share amount reported in current period compare to previous period (or compare to the same period if it is an amendment filing). Values can be "Acquire", "Dispose", "Restatement", "Restatement(+)","Restatement(-)". "Restatement(+)/(-)" stands for modification (increase/decrease) to the same period that has been reported before.
b(Current Holding shares - Last or same period holding shares) / Last or same period holding shares x 100%. The value is 100% for records without last period of holding.
cThe percentage of holding value relative to portfolio total.
Note: values subject to change as new filings become available.
COMMON STOCK CSV download realign column header
| Filing Date | Required Datea | Filing Type | Institution | Issuer Name | Aggregate Amount | Pct Shrs Os (%) | Sole Vtg Pow | Shrd Vtg Pow | Sole Dsp Pow | Shrd Dsp Pow | Shared Entityb | Latest 13F Periodc | Latest 13F Holdingd | Operatione | File Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-16 | 2024-12-12 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 12757562 | 19.5 | 0 | 12757562 | 0 | 12757562 | 2 | 2024-09-30 | 12757562 | no change | Link |
| 2024-12-16 | 2024-12-12 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 11469116 | 17.5 | 0 | 11469116 | 0 | 11469116 | 1 | - | - | - | Link |
| 2024-12-16 | 2024-12-12 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 1288446 | 2.0 | 0 | 1288446 | 0 | 1288446 | 1 | - | - | - | Link |
| 2024-11-14 | 2024-09-30 | SC 13G/A | VESTAL POINT CAPITAL, LP | LYRA THERAPEUTICS, INC. | 0 | 0.0 | 0 | 0 | 0 | 0 | 2 | 2024-03-31 | 800000 | dsp | Link |
| 2024-11-14 | 2024-09-30 | SC 13G/A | POINT72 ASSET MANAGEMENT, L.P. | LYRA THERAPEUTICS, INC. | 0 | 0.0 | 0 | 0 | 0 | 0 | 4 | 2024-03-31 | 2742460 | dsp | Link |
| 2024-08-15 | 2024-08-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 12757562 | 19.5 | 0 | 12757562 | 0 | 12757562 | 2 | 2024-06-30 | 12757562 | no change | Link |
| 2024-08-15 | 2024-08-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 11469116 | 17.5 | 0 | 11469116 | 0 | 11469116 | 1 | - | - | - | Link |
| 2024-08-15 | 2024-08-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 1288446 | 2.0 | 0 | 1288446 | 0 | 1288446 | 1 | - | - | - | Link |
| 2024-02-15 | 2023-12-31 | SC 13G/A | PURA VIDA INVESTMENTS, LLC | LYRA THERAPEUTICS, INC. | 1613844 | 3.1 | 0 | 1613844 | 0 | 1613844 | 2 | 2023-12-31 | 1413242 | acq | Link |
| 2024-02-14 | 2024-02-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 12757563 | 24.3 | 0 | 12757563 | 0 | 12757563 | 2 | 2023-12-31 | 12757562 | acq | Link |
| 2024-02-14 | 2024-02-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 11469117 | 21.8 | 0 | 11469117 | 0 | 11469117 | 1 | - | - | - | Link |
| 2024-02-14 | 2024-02-14 | SC 13D/A | PERCEPTIVE ADVISORS LLC | LYRA THERAPEUTICS, INC. | 1288446 | 2.5 | 0 | 1288446 | 0 | 1288446 | 1 | - | - | - | Link |
aDate of event which requires filing of this statement.
bThe number of entities that have exactly the same sole/shared voting/disposition power in the same 13G form.
cThe closest 13F filing period on or before the required date.
dThe holding shares reported in the closest 13F filing period on or before the required date.
eThe aggregated amount of shares reported in the 13G filing compare to the holding shares reported in the closest 13F filing (if any).
Note: The latest 13F holding shares and operation (as explained in superscript d and e, respectively) are for reference only, and subject to changes as new 13F filings become available. For a single 13G filing, only the largest aggregated amount is compared with 13F holding shares, others records (if any) are not compared and shown as short dash "-". When no 13F holding records were found, lastest 13F period/holding columns are blank.
Show up to 30 records per table for current tier. Download CSV to view up to 3000 records (Tier 1 and above. Access Guide)